Published in Medical Devices and Surgical Technology Week, November 22nd, 2009
"At the final follow-up, according to the Macnab classification an excellent and good outcome was achieved in 70.6% of the cases, and 78.4% were satisfied with their results. The failure rate was 15.7%(8 patients). Excluding those 8 failed cases who needed another reoperation, the average improvement calculated by Japanese Orthopaedic Association (JOA)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.